Related Experiment Video
Updated: May 10, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Vancomycin tolerance in Gram-positive cocci
Miriam Moscoso1, Mirian Domenech, Ernesto García
1Departamento de Microbiología Molecular y Biología de las Infecciones, Centro de Investigaciones Biológicas (CSIC) and CIBER de Enfermedades Respiratorias (CIBERES), Ramiro de Maeztu, 9, 28040 Madrid, Spain.
Abstract:
Vancomycin, a glycopeptide antimicrobial agent, represents the last line of defence against a wide range of multi-resistant Gram-positive pathogens such as enterococci, staphylococci and streptococci. However, vancomycin-resistant enterococci and staphylococci, along with vancomycin-tolerant clinical isolates, are compromising the therapeutic efficacy of vancomycin. It is conceivable that tolerance may emerge during prolonged vancomycin use. It has not been until recently, however, that the molecular basis of this tolerance began to be understood. Superoxide anions might be involved in the bactericidal activity of vancomycin in enterococci, and recent evidence suggests that the stringent response is partly responsible for vancomycin tolerance in Enterococcus faecalis. The mechanism of vancomycin tolerance in Staphylococcus aureus and Streptococcus pneumoniae is sometimes associated with a reduction of autolysin activity. Vancomycin tolerance in S. aureus and S. pneumoniae also appears to be somehow related with the two-component regulatory systems linked to cell envelope stress, although the precise molecular regulatory pathways remain poorly defined.
Insights
Vancomycin tolerance in bacteria is increasing, compromising this crucial antibiotic
Area of Science:
- Microbiology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Vancomycin is a critical antibiotic for treating multi-resistant Gram-positive infections.
- Emerging vancomycin resistance and tolerance in pathogens like enterococci, staphylococci, and streptococci threaten its clinical efficacy.
- Understanding the molecular mechanisms of vancomycin tolerance is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To explore the molecular basis of vancomycin tolerance in key bacterial pathogens.
- To identify potential pathways and factors contributing to reduced vancomycin susceptibility.
Main Methods:
- Review of recent evidence on vancomycin tolerance mechanisms.
- Analysis of studies investigating bacterial responses to vancomycin exposure.
- Focus on molecular pathways including stringent response, autolysin activity, and two-component regulatory systems.
Main Results:
- Vancomycin's bactericidal activity may involve superoxide anions in enterococci.
- The stringent response contributes to vancomycin tolerance in Enterococcus faecalis.
- Reduced autolysin activity and cell envelope stress-related two-component systems are implicated in vancomycin tolerance in Staphylococcus aureus and Streptococcus pneumoniae.
Conclusions:
- Vancomycin tolerance is a complex phenomenon with varied molecular underpinnings across different bacterial species.
- Further research is needed to fully elucidate the precise regulatory pathways involved in vancomycin tolerance.
- Understanding these mechanisms is essential for combating antimicrobial resistance and preserving vancomycin's therapeutic value.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial Protein Synthesis
Antibiotic Selection

